TopoGEN Topoisomerase Assay Kits

Tuesday, 08 April, 2025 | Supplied by: Sapphire Bioscience

Topoisomerases are enzymes that reduce DNA supercoiling by introducing cuts in DNA strands. TopoGEN recognises the unique details of topoisomerase drug discovery and provides innovative reagents and kits for topoisomerase research and mechanism-based drug development in cancer.

Kits are available to assay for topoisomerases (I, II, IV and gyrase) and Tdp1, to measure topo/DNA interactions in vivo and to identify new topoisomerase drugs. The company also offers a complete line of DNA substrates topo inhibitors, antibodies and kit replenishment reagents.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Content from other channels on our network

Why AI security is now a patient-safety issue

Construction commences on $100m New Epping Medical building

Balcony and nearby construction activities linked to RPA deaths

$10K fine for former nurse who forged registration certificates

Australian 'falls after stroke trial' sees 33% falls reduction in 12 months

From Intent to Impact: Why Execution Defines the Next Phase of Industrial Energy Efficiency

Refrigerant recovery: the overlooked lever in Australia's net-zero transition

Battery fires increase, prompting national battery stewardship

Call for electrification of Australian economy

Solar pumps transform water supply for remote NT farm

From reactive to predictive: how wireless condition monitoring is changing industrial maintenance

The vegetable oil refining process

Smarter, smaller, faster: How engineers are optimising edge AI with NPUs and model compression

Beijer Electronics X3 web: industrial reliability for web‍-‍based HMI with WebIQ

Control Station and Dimension Software partner on operations intelligence

TopoGEN Topoisomerase Assay Kits

Proteomics International PromarkerD LDT immunoassay (ELISA)

Cytek cFluor Human B Cell Monitoring Kit

Primerdesign exsig Mag RapidBead Pro Extraction Kit

Content from other channels on our network